← FDA Drug Approvals (Drugs@FDA)

CABERGOLINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: INGENUS PHARMS LLC · Approved 2018-08-01

Drug application

FDA Application #

ANDA204735

Application type

Abbreviated New Drug Application (Generic)

Brand name

CABERGOLINE

Generic name

CABERGOLINE

Active ingredients

CABERGOLINE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

INGENUS PHARMS LLC

Manufacturer

Ingenus Pharmaceuticals, LLC

First approval

2018-08-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown